Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Bain Capital injects £120m into Openwork to drive UK financial advice growth
Bain Capital injects £120m into Openwork to drive UK financial advice growth Bain Capital has completed a £120m investment in The Openwork Partnership, securing a stake of up to 30% in the UK-based financial advice network. The transaction, now approved by the...
McWin and TriSpan eye bite of Flat Iron in £50m steakhouse deal
McWin and TriSpan eye bite of Flat Iron in £50m steakhouse deal McWin Capital Partners and TriSpan have entered exclusive negotiations to acquire a significant stake in Flat Iron, a UK-based affordable steakhouse chain, according to Sky News. If successful, the deal...
Xeinadin targets £800m private equity sale as Exponent-backed firm prepares auction
Xeinadin targets £800m private equity sale as Exponent-backed firm prepares auction Xeinadin, the UK-based professional services group backed by private equity firm Exponent, is preparing for a sale that could exceed £800m, according to a report by The Times. The firm...